Table of Contents Author Guidelines Submit a Manuscript
Autism Research and Treatment
Volume 2016, Article ID 6763205, 6 pages
http://dx.doi.org/10.1155/2016/6763205
Research Article

Calcium and Vitamin D Supplement Prescribing Practices among Providers Caring for Children with Autism Spectrum Disorders: Are We Addressing Bone Health?

1Pediatric Endocrinology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
2Lurie Center for Autism, Massachusetts General Hospital for Children, Boston, MA, USA
3Pediatric Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA

Received 30 October 2015; Revised 25 January 2016; Accepted 9 February 2016

Academic Editor: Roberto Canitano

Copyright © 2016 Shylaja Srinivasan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Centers for Disease Control and Prevention, “Prevalence of autism spectrum disorder among children aged 8 years—autism and developmental disabilities monitoring network, 11 sites, United States, 2010,” Morbidity and Mortality Weekly Report Surveillance summaries, vol. 63, no. 2, pp. 1–21, 2014. View at Google Scholar
  2. J. H. Davies, B. A. J. Evans, and J. W. Gregory, “Bone mass acquisition in healthy children,” Archives of Disease in Childhood, vol. 90, no. 4, pp. 373–378, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Marí-Bauset, I. Zazpe, A. Mari-Sanchis, A. Llopis-González, and M. Morales-Suárez-Varela, “Food selectivity in autism spectrum disorders: a systematic review,” Journal of Child Neurology, vol. 29, no. 11, pp. 1554–1561, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Misra, D. Pacaud, A. Petryk, P. F. Collett-Solberg, and M. Kappy, “Vitamin D deficiency in children and its management: review of current knowledge and recommendations,” Pediatrics, vol. 122, no. 2, pp. 398–417, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. M. A. Levine, C. Zapalowski, and M. S. Kappy, “Disorders of calcium, phosphate, parathyroid hormone, and vitamin D,” in Principles and Practice of Pediatric Endocrinology, M. S. Kappy, D. B. Allen, and M. E. Geffner, Eds., Charles C Thomas, Springfield, Ill, USA, 2005. View at Google Scholar
  6. N. L. Lopez-Duran, M. Kovacs, and C. J. George, “Hypothalamic-pituitary-adrenal axis dysregulation in depressed children and adolescents: a meta-analysis,” Psychoneuroendocrinology, vol. 34, no. 9, pp. 1272–1283, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. R. D. Sheth, C. A. Wesolowski, J. C. Jacob et al., “Effect of carbamazepine and valproate on bone mineral density,” The Journal of Pediatrics, vol. 127, no. 2, pp. 256–262, 1995. View at Publisher · View at Google Scholar · View at Scopus
  8. A. M. Pack, M. J. Morrell, R. Marcus et al., “Bone mass and turnover in women with epilepsy on antiepileptic drug monotherapy,” Annals of Neurology, vol. 57, no. 2, pp. 252–257, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. Y. Sato, I. Kondo, S. Ishida et al., “Decreased bone mass and increased bone turnover with valproate therapy in adults with epilepsy,” Neurology, vol. 57, no. 3, pp. 445–449, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. C.-Y. Guo, G. M. Ronen, and S. A. Atkinson, “Long-term valproate and lamotrigine treatment may be a marker for reduced growth and bone mass in children with epilepsy,” Epilepsia, vol. 42, no. 9, pp. 1141–1147, 2001. View at Publisher · View at Google Scholar · View at Scopus
  11. J. R. Bostwick, S. K. Guthrie, and V. L. Ellingrod, “Antipsychotic-induced hyperprolactinemia,” Pharmacotherapy, vol. 29, no. 1, pp. 64–73, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. B. Liu, G. Anderson, N. Mittmann, T. To, T. Axcell, and N. Shear, “Use of selective serotonin-reuptake inhibitors or tricyclic antidepressants and risk of hip fractures in elderly people,” The Lancet, vol. 351, no. 9112, pp. 1303–1307, 1998. View at Publisher · View at Google Scholar · View at Scopus
  13. A. M. Neumeyer, A. Gates, C. Ferrone, H. Lee, and M. Misra, “Bone density in peripubertal boys with autism spectrum disorders,” Journal of Autism and Developmental Disorders, vol. 43, no. 7, pp. 1623–1629, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. A. M. Neumeyer, J. A. O'Rourke, A. Massa et al., “Brief report: bone fractures in children and adults with autism spectrum disorders,” Journal of Autism and Developmental Disorders, vol. 45, no. 3, pp. 881–887, 2015. View at Publisher · View at Google Scholar
  15. M. F. Holick, N. C. Binkley, H. A. Bischoff-Ferrari et al., “Evaluation, treatment, and prevention of vitamin D deficiency: an endocrine society clinical practice guideline,” The Journal of Clinical Endocrinology and Metabolism, vol. 96, no. 7, pp. 1911–1930, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Haap, E. Heller, C. Thamer, O. Tschritter, N. Stefan, and A. Fritsche, “Association of serum phosphate levels with glucose tolerance, insulin sensitivity and insulin secretion in non-diabetic subjects,” European Journal of Clinical Nutrition, vol. 60, no. 6, pp. 734–739, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. C. A. Calarge, T. L. Burns, J. A. Schlechte, and B. S. Zemel, “Longitudinal examination of the skeletal effects of selective serotonin reuptake inhibitors and risperidone in boys,” The Journal of Clinical Psychiatry, vol. 76, no. 5, pp. 607–613, 2015. View at Google Scholar
  18. P. A. Stewart, S. L. Hyman, B. L. Schmidt et al., “Dietary supplementation in children with autism spectrum disorders: common, insufficient, and excessive,” Journal of the Academy of Nutrition and Dietetics, vol. 115, no. 8, pp. 1237–1248, 2015. View at Publisher · View at Google Scholar